Ken Griffin Amneal Pharmaceuticals, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $73,432 - $97,407	-13,700 Reduced 83.54%	2,700 $17,000
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $6,288 - $7,608	1,200 Added 7.89%	16,400 $99,000
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $45,024 - $83,214	13,400 Added 744.44%	15,200 $92,000
Q3 2023 Nov 14, 2023	SELL	$2.76 - $4.59 $8,280 - $13,770	-3,000 Reduced 62.5%	1,800 $7,000
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $1,064 - $2,480	-800 Reduced 14.29%	4,800 $14,000
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $12,446 - $26,460	-9,800 Reduced 63.64%	5,600 $7,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $30,184 - $40,194	15,400 New	15,400 $30,000

183

138M

234K

45.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.29B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.